Clinical Trials

Showing trials with last updates posted in 2026.

NCT06649812 | RECRUITING | PHASE2
120 participants

Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-03
Start Date:
2025-10-07
Completion:
2028-09-01
Conditions
  • High Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements
  • Recurrent Diffuse Large B-Cell Lymphoma
  • Recurrent Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type
  • Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
  • Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements
  • Recurrent High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements
  • Recurrent High Grade B-Cell Lymphoma, Not Otherwise Specified
  • Recurrent T-Cell/Histiocyte-Rich Large B-Cell Lymphoma
  • Refractory Diffuse Large B-Cell Lymphoma
  • Refractory Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type
  • Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
  • Refractory High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements
  • Refractory High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements
  • Refractory High Grade B-Cell Lymphoma, Not Otherwise Specified
  • Refractory T-Cell/Histiocyte-Rich Large B-Cell Lymphoma
Interventions
  • PROCEDURE
  • DRUG
  • BIOLOGICAL
No Results Yet
NCT06635980 | RECRUITING | PHASE2
120 participants

Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-03
Start Date:
2025-05-14
Completion:
2031-10-21
Conditions
  • Anatomic Stage I Breast Cancer AJCC v8
  • Anatomic Stage II Breast Cancer AJCC v8
  • Anatomic Stage III Breast Cancer AJCC v8
  • Breast Carcinoma
  • Triple-Negative Breast Carcinoma
Interventions
  • PROCEDURE
  • DRUG
  • RADIATION
  • OTHER
No Results Yet
NCT06617169 | ACTIVE_NOT_RECRUITING | PHASE1
12 participants

Dose-Escalation of MNPR-101-PCTA-177Lu in Solid Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-03
Start Date:
2024-10-08
Completion:
2027-01-31
Conditions
  • Solid Tumor, Adult
  • Bladder Cancer
  • Urothelial Carcinoma
  • Triple-negative Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Gastric Cancer
  • Ovarian Cancer
  • Pancreatic Cancer
Interventions
  • DRUG
No Results Yet
NCT06589804 | RECRUITING | PHASE3
158 participants

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-03
Start Date:
2025-03-27
Completion:
2029-11-30
Conditions
  • Metastatic Head and Neck Squamous Cell Carcinoma
  • Metastatic Hypopharyngeal Squamous Cell Carcinoma
  • Metastatic Laryngeal Squamous Cell Carcinoma
  • Metastatic Oral Cavity Squamous Cell Carcinoma
  • Metastatic Oropharyngeal Squamous Cell Carcinoma
  • Recurrent Head and Neck Squamous Cell Carcinoma
  • Recurrent Hypopharyngeal Squamous Cell Carcinoma
  • Recurrent Laryngeal Squamous Cell Carcinoma
  • Recurrent Neck Squamous Cell Carcinoma of Unknown Primary
  • Recurrent Oral Cavity Squamous Cell Carcinoma
  • Recurrent Oropharyngeal Squamous Cell Carcinoma
  • Refractory Head and Neck Squamous Cell Carcinoma
  • Refractory Hypopharyngeal Squamous Cell Carcinoma
  • Refractory Laryngeal Squamous Cell Carcinoma
  • Refractory Oral Cavity Squamous Cell Carcinoma
  • Refractory Oropharyngeal Squamous Cell Carcinoma
  • Stage IV Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8
  • Stage IV Hypopharyngeal Carcinoma AJCC v8
  • Stage IV Laryngeal Cancer AJCC v8
  • Stage IV Lip and Oral Cavity Cancer AJCC v8
  • Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8
Interventions
  • PROCEDURE
  • BIOLOGICAL
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page